Michael Morrissey
Chief Executive Officer en EXELIXIS, INC. .
Fortuna: 59 M $ al 31/03/2024
Perfil
En la actualidad, Michael M. Morrissey ocupa el cargo de presidente, director general y consejero de Exelixis, Inc. El Dr. Morrissey también forma parte del consejo de administración de XWPharma Ltd. En su anterior carrera, el Dr. Morrissey ocupó el puesto de científico principal en Ciba-Geigy Corp. y de vicepresidente de investigación de descubrimientos en Berlex Biosciences. Michael M. Morrissey se doctoró en la Universidad de Harvard y se licenció en la Universidad de Wisconsin.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EXELIXIS, INC.
0.82% | 23/02/2024 | 2 492 969 ( 0.82% ) | 59 M $ | 31/03/2024 |
| 18/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Michael Morrissey
| Empresas | Cargo | Inicio |
|---|---|---|
| EXELIXIS, INC. | Chief Executive Officer | 22/07/2010 |
| VERA THERAPEUTICS, INC. | Chairman | 24/05/2022 |
XWPharma Ltd.
 XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Director/Board Member | 16/12/2020 |
Antiguos cargos conocidos de Michael Morrissey.
| Empresas | Cargo | Fin |
|---|---|---|
CERo Therapeutics, Inc.
 CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Director/Board Member | 01/11/2022 |
| Berlex Biosciences | Corporate Officer/Principal | 01/01/2000 |
| Ciba-Geigy Corp. | Chief Tech/Sci/R&D Officer | 01/01/1991 |
Formación de Michael Morrissey.
| Harvard University | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| VERA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
| Berlex Biosciences | |
XWPharma Ltd.
XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Health Technology |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Michael Morrissey
